A resolution expressing support for the designation of September 2025 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

9/22/2025, 2:35 PM

Summary of Bill SRES 416

The bill, introduced in the 119th Congress as Senate Resolution 416 on September 19, 2025, seeks to express support for designating September 2025 as "Sickle Cell Disease Awareness Month" to raise awareness about sickle cell disease nationwide. It aims to educate communities about the disease, advocate for research, promote early detection methods, enhance effective treatments, and implement preventative care programs to address complications and related conditions resulting from sickle cell disease.

Current Status of Bill SRES 416

Bill SRES 416 is currently in the status of Passed in Senate since September 19, 2025. Bill SRES 416 was introduced during Congress 119 and was introduced to the Senate on September 19, 2025. Bill SRES 416's most recent activity was Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6798; text: CR S6795) as of September 19, 2025

Bipartisan Support of Bill SRES 416

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill SRES 416

Primary Policy Focus

Alternate Title(s) of Bill SRES 416

A resolution expressing support for the designation of September 2025 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.